Results 151 to 160 of about 2,125,053 (404)
The detection of bacteria and matrix proteins on clinically benign and pathologic implants [PDF]
Adams+52 more
core +2 more sources
Spartan Daily, November 13, 1991 [PDF]
Volume 97, Issue 52https://scholarworks.sjsu.edu/spartandaily/8189/thumbnail ...
San Jose State University, School of Journalism and Mass Communications
core +2 more sources
Experience with Soybean Oil-filled Breast Implants in a Swedish Surgical Practice [PDF]
Per Opitz, V. Leroy Young
openalex +1 more source
In vitro cancer models are advantageous for studying important processes such as tumorigenesis, cancer growth, invasion, and metastasis. The complexity and biological relevance increase depending on the model structure, organization, and composition of materials and cells.
Kyndra S. Higgins+2 more
wiley +1 more source
Nipple‑sparing mastectomies: Clinical outcomes from a single academic institution [PDF]
Conant, Leah+5 more
core +2 more sources
The Regulation-Litigation Interaction [PDF]
This paper provides a preview of a new Joint Center book on the relationship between regulation and litigation.
Viscusi, W. Kip
core +1 more source
Lifetime risk from polyurethane covered breast implants. [PDF]
Kenneth Kulig
openalex +1 more source
Key Trends and Insights in Smart Polymeric Skin Wearable Patches
Intelligent polymers, which respond to various physical and biological stimuli, are explored for the development of skin wearable patches in biomedical applications. Smart polymers, also known as intelligent or stimuli‐responsive polymers, play a crucial role in the development of advanced wearable patches due to their versatility and softness.
Sergio J. Peñas‐Núñez+2 more
wiley +1 more source
Paolo Fanzio,1,* Jason Hammer,1,* Nancy Van Laeken2,* 1Plastic Surgery & Regenerative Medicine, Allergan Aesthetics, an AbbVie Company, Irvine, CA, USA; 2Division of Plastic Surgery, University of British Columbia, Vancouver ...
Fanzio P, Hammer J, Van Laeken N
doaj
A Critical Examination of the FDA’s Efforts to Preempt Failure-to-Warn Claims [PDF]
This article explores the legality and wisdom of the FDA’s effort to persuade courts to find most failure-to-warn claims preempted. The article first analyzes the FDA’s justifications for reversing its long-held views to the contrary and explains why ...
Kessler, David A., Vladeck, David C.
core +1 more source